Ongoing research aims to better understand the mechanisms by which BRCA1 and BRCA2 mutations lead to cancer and to develop targeted therapies. Advances in genetic engineering and personalized medicine hold promise for more effective prevention and treatment strategies. Public health initiatives continue to focus on improving access to genetic testing and counseling services.
